Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A large‐scale transcriptome analysis identified ELANE and PRTN3 as novel methylation prognostic signatures for clear cell renal cell carcinoma

6 Sept 2019

Abstract excerpt

DNA methylation was involved in the progress of many types of cancer including clear cell renal cell carcinomas (ccRCCs). This study aimed to identify the prognostic DNA methylation biomarkers for the ccRCCs by a large-scale RNA-seq analysis. The DNA methylation data and the corresponding clinical information of the patients with ccRCCs were extracted from TCGA database and randomly divided into the training...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Epigenetics and DNA Methylation
Share to Renal and related cancers
Share to Renal cell carcinoma treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31490025
DOI: 10.1002/jcp.29162

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A large‐scale transcriptome analysis identified ELANE and PRTN3 as novel methylation prognostic signatures for clear cell renal cell carcinomaPMID 31490025Read ↗

A CpG-methylation-based assay to predict survival in clear cell renal cell carcinomaSemantic proximity Read ↗

Identification and Comprehensive Validation of a DNA Methylation-Driven Gene-Based Prognostic Model for Clear Cell Renal Cell CarcinomaSemantic proximity Read ↗

DNA methylation expression patterns predict outcome of clear cell renal cell carcinomaSemantic proximity Read ↗

Identification of a m6A RNA methylation regulators-based signature for predicting the prognosis of clear cell renal carcinomaSemantic proximity Read ↗

Construction and validation of an m6A RNA methylation regulator prognostic model for early-stage clear cell renal cell carcinomaSemantic proximity Read ↗

Construction and Validation of a Prognostic Nomogram for Clear Cell Renal Cell Carcinoma Based on DNA Methylation-driven Differentially Expressed GenesSemantic proximity Read ↗

Prognostic Value of an m5C RNA Methylation Regulator-Related Signature for Clear Cell Renal Cell CarcinomaSemantic proximity Read ↗

Identifying prognostic biomarkers based on aberrant DNA methylation in kidney renal clear cell carcinomaSemantic proximity Read ↗

Epigenomics of clear cell renal cell carcinoma: mechanisms and potential use in molecular pathology.Semantic proximity Read ↗

N6-methyladenosine Methylation Related Immune Biomarkers Correlates With Clinicopathological Characteristics and Prognosis in Clear Cell Renal Cell CarcinomaSemantic proximity Read ↗

Identification and validation of a DNA methylation-driven gene-based prognostic model for clear cell renal cell carcinomaSemantic proximity Read ↗

A methylomics-correlated nomogram predicts the recurrence free survival risk of kidney renal clear cell carcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.